PACEOMICS Value-Engineered Translation (VET) Framework is a key component of just-annouced $25M Networks of Centres of Excellence funding: Biotherapeutics for Cancer Treatment – BioCanRx

BioCanRx Theme IV: Value-Engineered Translation (VET) lead by PACEOMICS Chris McCabe and Tania Bubela at the University of Alberta.

Read more: NCE press release. Ottawa Hospital Research Institute press release